205 related articles for article (PubMed ID: 21916574)
1. When is contralateral mastectomy warranted in unilateral breast cancer?
Barry M; Sacchini V
Expert Rev Anticancer Ther; 2011 Aug; 11(8):1209-14. PubMed ID: 21916574
[TBL] [Abstract][Full Text] [Related]
2. Contralateral prophylactic mastectomy for patients with unilateral breast cancer.
Tuttle T; Habermann E; Abraham A; Emory T; Virnig B
Expert Rev Anticancer Ther; 2007 Aug; 7(8):1117-22. PubMed ID: 18028020
[TBL] [Abstract][Full Text] [Related]
3. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment.
Tuttle TM; Habermann EB; Grund EH; Morris TJ; Virnig BA
J Clin Oncol; 2007 Nov; 25(33):5203-9. PubMed ID: 17954711
[TBL] [Abstract][Full Text] [Related]
4. Contentment with quality of life among breast cancer survivors with and without contralateral prophylactic mastectomy.
Geiger AM; West CN; Nekhlyudov L; Herrinton LJ; Liu IL; Altschuler A; Rolnick SJ; Harris EL; Greene SM; Elmore JG; Emmons KM; Fletcher SW
J Clin Oncol; 2006 Mar; 24(9):1350-6. PubMed ID: 16549829
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project.
Herrinton LJ; Barlow WE; Yu O; Geiger AM; Elmore JG; Barton MB; Harris EL; Rolnick S; Pardee R; Husson G; Macedo A; Fletcher SW
J Clin Oncol; 2005 Jul; 23(19):4275-86. PubMed ID: 15795415
[TBL] [Abstract][Full Text] [Related]
6. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.
Metcalfe KA; Lubinski J; Ghadirian P; Lynch H; Kim-Sing C; Friedman E; Foulkes WD; Domchek S; Ainsworth P; Isaacs C; Tung N; Gronwald J; Cummings S; Wagner T; Manoukian S; Møller P; Weitzel J; Sun P; Narod SA;
J Clin Oncol; 2008 Mar; 26(7):1093-7. PubMed ID: 18195327
[TBL] [Abstract][Full Text] [Related]
7. Should the use of contralateral prophylactic mastectomy be increasing as it is?
Wood WC
Breast; 2009 Oct; 18 Suppl 3():S93-5. PubMed ID: 19914552
[TBL] [Abstract][Full Text] [Related]
8. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer.
Arrington AK; Jarosek SL; Virnig BA; Habermann EB; Tuttle TM
Ann Surg Oncol; 2009 Oct; 16(10):2697-704. PubMed ID: 19653045
[TBL] [Abstract][Full Text] [Related]
9. Current status of prophylactic mastectomy.
Ghosh K; Hartmann LC
Oncology (Williston Park); 2002 Oct; 16(10):1319-25; discussion 1325, 1329-30, 1332. PubMed ID: 12435203
[TBL] [Abstract][Full Text] [Related]
10. Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution.
Jones NB; Wilson J; Kotur L; Stephens J; Farrar WB; Agnese DM
Ann Surg Oncol; 2009 Oct; 16(10):2691-6. PubMed ID: 19506956
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic mastectomy: who needs it, when and why.
Burke EE; Portschy PR; Tuttle TM
J Surg Oncol; 2015 Jan; 111(1):91-5. PubMed ID: 24965368
[TBL] [Abstract][Full Text] [Related]
12. Indications for sentinel lymph node biopsy in the setting of prophylactic mastectomy.
Laronga C; Lee MC; McGuire KP; Meade T; Carter WB; Hoover S; Cox CE
J Am Coll Surg; 2009 Dec; 209(6):746-52; quiz 800-1. PubMed ID: 19959044
[TBL] [Abstract][Full Text] [Related]
13. Targeted tailored management of the breast cancer patient at risk for harboring a germline mutation-current trends affecting the selection of patients considering surgical prophylaxis for breast cancer.
Silva E
Breast J; 2009; 15 Suppl 1():S76-80. PubMed ID: 19775334
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic bilateral mastectomy and contralateral prophylactic mastectomy.
Chagpar AB
Surg Oncol Clin N Am; 2014 Jul; 23(3):423-30. PubMed ID: 24882342
[TBL] [Abstract][Full Text] [Related]
15. Predictors of and satisfaction with bilateral prophylactic mastectomy.
Stefanek ME; Helzlsouer KJ; Wilcox PM; Houn F
Prev Med; 1995 Jul; 24(4):412-9. PubMed ID: 7479633
[TBL] [Abstract][Full Text] [Related]
16. [Preventive surgical prcedures for inherited risk of breast cancer].
Menke-Pluymers MB; Seynaeve C; van Geel AN; Klijn JG; Meijers-Heijboer EJ; Eggermont AM
Ned Tijdschr Geneeskd; 2005 Nov; 149(48):2663-7. PubMed ID: 16358615
[TBL] [Abstract][Full Text] [Related]
17. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
[TBL] [Abstract][Full Text] [Related]
18. Surveillance of prophylactic mastectomy: trends in use from 1995 through 2005.
McLaughlin CC; Lillquist PP; Edge SB
Cancer; 2009 Dec; 115(23):5404-12. PubMed ID: 19787635
[TBL] [Abstract][Full Text] [Related]
19. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ.
Tuttle TM; Jarosek S; Habermann EB; Arrington A; Abraham A; Morris TJ; Virnig BA
J Clin Oncol; 2009 Mar; 27(9):1362-7. PubMed ID: 19224844
[TBL] [Abstract][Full Text] [Related]
20. Increase in contralateral prophylactic mastectomy: echoes of a bygone era? Surgical trends for unilateral breast cancer.
Stucky CC; Gray RJ; Wasif N; Dueck AC; Pockaj BA
Ann Surg Oncol; 2010 Oct; 17 Suppl 3():330-7. PubMed ID: 20853055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
